Elomatic-Pharmalab Consulting And Engineering Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 25-07-2024
- Paid Up Capital ₹ 5.17 Cr
as on 25-07-2024
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.04 M
as on 25-07-2024
- Revenue 19.67%
(FY 2023)
- Profit -19.63%
(FY 2023)
- Ebitda 21.02%
(FY 2023)
- Net Worth 20.35%
(FY 2023)
- Total Assets 10.40%
(FY 2023)
About Elomatic-Pharmalab Consulting And Engineering
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 5.17 Cr.
The company has closed loans amounting to ₹6.04 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Patrik Rautaheimo, Vishal Shah, Tero Tuomela, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73100MH2004PTC149278
- Company No.
149278
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane West, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Elomatic-Pharmalab Consulting And Engineering Private Limited offer?
Elomatic-Pharmalab Consulting And Engineering Private Limited offers a wide range of products and services, including Electrical & Signaling Contractors, Power Engineering Service, IT Solutions, Server Virtualization Service, Turnkey Solutions, Water Management Solution, Measurement Instrument, Electrical Measuring Instruments, Crane, Kone cranes.
Who are the key members and board of directors at Elomatic-Pharmalab Consulting And Engineering?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tero Tuomela  | Director | 30-Sep-2015 | Current |
| Patrik Rautaheimo | Director | 11-Aug-2020 | Current |
Vishal Shah  | Director | 11-Aug-2020 | Current |
| Umesh Shah | Director | 27-Oct-2004 | Current |
| Mona Daniela | Director | 21-Apr-2022 | Current |
Financial Performance of Elomatic-Pharmalab Consulting And Engineering.
Elomatic-Pharmalab Consulting And Engineering Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.67% increase. The company also saw a substantial fall in profitability, with a 19.63% decrease in profit. The company's net worth Soared by an impressive increase of 20.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elomatic-Pharmalab Consulting And Engineering?
In 2023, Elomatic-Pharmalab Consulting And Engineering had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmalab India Private Limited.Active 18 years 10 monthsVishal Shah and Umesh Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 16 Jun 2021 | ₹0.74 M | Satisfied |
Canara Bank Creation Date: 05 Mar 2014 | ₹2.50 M | Satisfied |
Canara Bank Creation Date: 17 Feb 2014 | ₹2.50 M | Satisfied |
How Many Employees Work at Elomatic-Pharmalab Consulting And Engineering?
Unlock and access historical data on people associated with Elomatic-Pharmalab Consulting And Engineering, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elomatic-Pharmalab Consulting And Engineering, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elomatic-Pharmalab Consulting And Engineering's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
